Drug Profile
OGD 204
Alternative Names: OGD204Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator OGD2 Pharma
- Class Immunoconjugates
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer